Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Expression of ORAII, a plasma membrane resident subunit of the CRAC channel, in rodent and non-rodent species.

Autor: Guzman R; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Valente EG; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Pretorius J; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Pacheco E; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Qi M; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Bennett BD; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Fong DH; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Lin FF; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., Bi V; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California., McBride HJ; Departments of Pathology (RG, EGV, JP, EP, MQ), Amgen, Inc. Thousand Oaks, CaliforniaTherapeutic Discovery (FFL, VB), Amgen, Inc. Thousand Oaks, CaliforniaDiscovery Toxicology (HJM), Amgen, Inc. Thousand Oaks, CaliforniaInflammation Research (BDB, DHF), Amgen, Inc. Thousand Oaks, California hmcbride@amgen.com.

Publikováno v: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [J Histochem Cytochem] 2014 Dec; Vol. 62 (12), pp. 864-78. Date of Electronic Publication: 2014 Sep 23.

Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury.

Autor: Li X; Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, CA, USA., Grisanti M, Fan W, Asuncion FJ, Tan HL, Dwyer D, Han CY, Yu L, Lee J, Lee E, Barrero M, Kurimoto P, Niu QT, Geng Z, Winters A, Horan T, Steavenson S, Jacobsen F, Chen Q, Haldankar R, Lavallee J, Tipton B, Daris M, Sheng J, Lu HS, Daris K, Deshpande R, Valente EG, Salimi-Moosavi H, Kostenuik PJ, Li J, Liu M, Li C, Lacey DL, Simonet WS, Ke HZ, Babij P, Stolina M, Ominsky MS, Richards WG

Publikováno v: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2011 Nov; Vol. 26 (11), pp. 2610-21.

L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.

Autor: Valente EG; Division of Urology, Research and Education Institute, Harbor-UCLA Medical Center, Torrance, CA, USA., Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF

Publikováno v: Nitric oxide : biology and chemistry [Nitric Oxide] 2003 Dec; Vol. 9 (4), pp. 229-44.